by Pamela James, Ph.D., Vice President, Product, Vector Laboratories
Realizing the dream of truly personalized medicine is a dominant goal in the biomedical research landscape. However, reaching this milestone is not only about advancing therapeutics for rare and complex diseases—a deeper understanding of disease mechanisms and improvements in our capacity to identify them will be necessary steps in the mission. Biomarker discovery is a fundamental arm of progress in personalized medicine that has been revolutionized by advances in exploring genomic, proteomic, and metabolomic markers of health and disease. One promising sector remains largely unexplored: glycomic biomarkers, which encompass the glycans and patterns of glycosylation present in the body.
Read more on Labcompare.